ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.13, ss.115-120, 2013 (SCI İndekslerine Giren Dergi)
Objective: Behcet's disease (BD) is a systemic vasculitis, capable of involving all types of vessels. Endothelial dysfunction (ED) has been previously documented in BD. Previous studies showed that nebivolol might improve endothelial functions in endothelial dysfunction. The aim of our study is to assess the effects of nebivolol on endothelial dysfunction in patients with Behcet's disease.